Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.42 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1526872 | 1.00 | DNM1 (0.50) | DNM1USP2SPHK1HTTMEN1 | |
| SCHEMBL1095622 | 1.00 | DNM1 (0.50) | DNM1USP2SPHK1HTTMEN1 | |
| SCHEMBL28358020 | 1.00 | DNM1 (0.50) | DNM1USP2SPHK1HTTMEN1 | |
| SCHEMBL10880891 | 1.00 | DNM1 (0.50) | DNM1USP2SPHK1HTTMEN1 | |
| SCHEMBL5537012 | 1.00 | DNM1 (0.50) | DNM1USP2SPHK1HTTMEN1 | |
| SCHEMBL1096441 | 1.00 | DNM1 (0.50) | DNM1USP2SPHK1HTTMEN1 | |
| SCHEMBL6945069 | 1.00 | DNM1 (0.50) | DNM1USP2SPHK1HTTMEN1 | |
| SCHEMBL10882065 | 1.00 | DNM1 (0.50) | DNM1USP2SPHK1HTTMEN1 | |
| SCHEMBL10878345 | 1.00 | DNM1 (0.50) | DNM1USP2SPHK1HTTMEN1 | |
| SCHEMBL4636144 | 1.00 | DNM1 (0.50) | DNM1USP2SPHK1HTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 915 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11193079-B2 | Glycol ether neo-esters, lubricating oil compositions containing same and processes for making same | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2021-12-07 | — | — | US | claimed |
| WO-2021021559-A1 | A MODULAR, INTEGRATED PROCESS AND APPARATUS FOR EXTRACTING, REFINING AND REMEDIATING ACTIVE SUBSTANCES FROM PLANT MATERIAL | BIOMASS OIL SEPARATION SOLUTIONS, LLC (US) | 2021-02-04 | — | — | WO | claimed |
| US-20200399552-A1 | Glycol Ether Neo-Esters, Lubricating Oil Compositions Containing Same And Processes For Making Same | EXXONMOBIL RES & ENG CO (US) | 2020-12-24 | — | — | US | claimed |
| US-10799546-B1 | Modular, integrated process and apparatus for extracting, refining and remediating active substances from plant material | BIOMASS OIL SEPARATION SOLUTIONS, LLC (US) | 2020-10-13 | — | — | US | claimed |
| CN-111187311-A | 1, 2-trans-maltoside surfactant and preparation method thereof | 湘潭大学 | 2020-05-22 | — | — | CN | claimed |
| CN-107011395-B | N-acetylglucosamine compounds | 湘潭大学 | 2020-01-03 | — | — | CN | claimed |
| US-10455831-B2 | Liquid material systems with multifunctional organometallic additives | DMR INTERNATIONAL, INC. (US) | 2019-10-29 | — | — | US | claimed |
| US-10160903-B2 | Multi-functional additive for oil or gas operations | HALLIBURTON ENERGY SERVICES, INC. (US) | 2018-12-25 | — | — | US | claimed |
| CN-107109201-A | Polymer composition | 雪佛龙美国公司 | 2017-08-29 | — | — | CN | claimed |
| US-20160312105-A1 | MULTI-FUNCTIONAL ADDITIVE FOR OIL OR GAS OPERATIONS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2016-10-27 | — | — | US | claimed |
| EP-0251621-A2 | Fountain solutions and printing processes utilising them | SUN CHEMICAL CORPORATION (US) | 1988-01-07 | — | — | EP | claimed |
| EP-0162908-A4 | PREPARATION OF ALKALINE EARTH METAL ORGANOMETALLIC COMPOUNDS. | LITHIUM CORP (US) | 1986-04-15 | — | — | EP | claimed |
| EP-0162908-A1 | PREPARATION OF ALKALINE EARTH METAL ORGANOMETALLIC COMPOUNDS | LITHIUM CORPORATION OF AMERICA (US) | 1985-12-04 | — | — | EP | claimed |
| WO-1985002176-A1 | PREPARATION OF ALKALINE EARTH METAL ORGANOMETALLIC COMPOUNDS | LITHIUM CORPORATION OF AMERICA (US) | 1985-05-23 | — | — | WO | claimed |
| US-4413015-A | Storage stable water-dilutable acid adducted epoxy based coating for metal food contact surfaces | MOBIL OIL CORPORATION (US) | 1983-11-01 | — | — | US | claimed |
| EP-0009526-A1 | Water-solubilizable epoxy resin and coating composition comprising the resin for metal food contact surfaces | MOBIL OIL CORPORATION (US) | 1980-04-16 | — | — | EP | claimed |
| US-4151305-A | SOLUBILIZED WITH TERTIARY AMINE, AMMONIA OR AMMONIUM HYDROXIDE, COMBINED WITH AMINOPLAST | MOBIL OIL CORPORATION (US) | 1979-04-24 | — | — | US | claimed |
| US-4145324-A | COATINGS BASED ON HYDROLYZED EPOXY RESINS | MOBIL OIL CORPORATION (US) | 1979-03-20 | — | — | US | claimed |
| US-4128515-A | FOR FOOD PACKAGING CONTAINER INTERIORS | MOBIL OIL CORPORATION (US) | 1978-12-05 | — | — | US | claimed |
| US-4105614-A | ADDUCT OF A BISPHENOL AND A DIGLYCIDYL ETHER OF A BISPHENOL | MOBIL OIL CORPORATION (US) | 1978-08-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11193079-B2 | Glycol ether neo-esters, lubricating oil compositions containing same and processes for making same | ELOVL5, ELOVL1, NAPEPLD | DNM1 1782/4885USP2 2570/4885SPHK1 2234/4885 |
| US-20200399552-A1 | Glycol Ether Neo-Esters, Lubricating Oil Compositions Containing Same And Processes For Making Same | ELOVL5, ELOVL1, NAPEPLD | DNM1 1782/4885USP2 2570/4885SPHK1 2234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.